Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Kestra Medical Technologies, Ltd. - Common Stock (NQ:KMTS)

29.27 +0.81 (+2.85%)
Streaming Delayed Price Updated: 12:35 PM EDT, Sep 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Kestra Medical Technologies, Ltd. - Common Stock

News headline image
Kestra (KMTS) Q1 2027 Earnings Call Transcript ↗
Gross margins hit 56.5% as revenue surged 60% and management raised full-year guidance. 
Via The Motley Fool
Topics Earnings Supply Chain
News headline image
Kestra Medical Technologies Q1 Earnings Call Highlights ↗
Kestra Medical Technologies (NASDAQ:KMTS) reported first-quarter fiscal 2027 revenue of $31 million, with President and Chief Executive Officer Brian Webster saying revenue rose 60% from a year earlier... 
Via MarketBeat
Topics Earnings
What's going on in today's after hours session ↗
Via Chartmill
Kestra Medical Technologies (NASDAQ:KMTS) Revenue Beat and EPS Miss Create Mixed Setup After Recent Rally ↗
Via Chartmill
Kestra Medical Technologies (NASDAQ:KMTS) Reports Q3 Revenue Beat but Stock Falls on In-Line Losses ↗
Via Chartmill
News headline image
Kestra Medical (KMTS) Q4 2026 Earnings Call Transcript ↗
Revenue surged 66% in Q4 as prescriptions climbed 63% year over year. 
Via The Motley Fool
Topics Earnings
News headline image
Kestra Medical Technologies Q4 Earnings Call Highlights ↗
Kestra Medical Technologies (NASDAQ:KMTS) reported a sharp increase in fourth-quarter revenue and issued fiscal 2027 guidance calling for continued growth, as executives said demand for the company’s... 
Via MarketBeat
Topics Earnings
News headline image
What a $312,000 Kestra Insider Sale Signals After 25% Stock Gains ↗
This cardiac device innovator saw a notable insider sale, as routine portfolio moves continue amid its push in digital health solutions. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Bicara Stock Is Up 50%, and One Biotech Investor Has Made It a 29% Portfolio Bet ↗
This clinical-stage biotech develops bifunctional antibody therapies targeting solid tumors for oncology providers and institutions. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Alumis Stock Is Up Over 300%. One Major Healthcare Investor Is Cutting Back ↗
Alumis Inc. develops clinical-stage therapies targeting autoimmune and neuroinflammatory diseases using allosteric TYK2 inhibitors. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Kestra Medical Grew Revenue 63%. One Fund Still Trimmed 351,000 Shares ↗
Kestra Medical Technologies develops advanced wearable cardiac devices and digital health solutions for cardiovascular care providers. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
The Kestra Director Who Built and Sold a Device Company Keeps Buying Stock ↗
Kestra Medical Technologies, a specialist in wearable cardiac devices, reported a recent insider buy amid a year of share price declines. 
Via The Motley Fool
Topics Derivatives Regulatory Compliance
News headline image
Kestra Medical (KMTS) Q3 2026 Earnings Transcript ↗
Kestra Medical (KMTS) Q3 2026 Earnings Transcript 
Via The Motley Fool
Topics Initial Public Offering
Get insights into the top gainers and losers of Friday's pre-market session. ↗
Via Chartmill
News headline image
Kestra Medical (KMTS) Q2 2026 Earnings Transcript ↗
Kestra Medical (KMTS) Q2 2026 Earnings Transcript 
Via The Motley Fool
Topics Initial Public Offering
News headline image
Kestra Medical Technologies (NASDAQ:KMTS) Posts Mixed Q2 2026 Results, Shares Drop on Wider Loss ↗
Kestra Medical beats Q2 2026 revenue estimates but posts a wider-than-expected loss, triggering a sharp after-hours stock decline. 
Via Chartmill
News headline image
This Lumentum Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
Kestra Revenue Jumps 52% in Fiscal Q1 ↗
Via The Motley Fool
News headline image
Wondering what's happening in today's after-hours session? ↗
The US market regular session of Thursday is over, let's have a look at the top gainers and losers in the after hours session today. 
Via Chartmill
News headline image
KESTRA MEDICAL TECHNOLOGIES (NASDAQ:KMTS) Surpasses Q1 2026 Earnings and Revenue Estimates ↗
Kestra Medical beats Q1 FY26 revenue and EPS estimates, sending its stock up nearly 9% in after-hours trading on strong operational performance. 
Via Chartmill
News headline image
Earnings Scheduled For September 11, 2025 ↗
 
Via Benzinga
News headline image
Tuesday's after hours session: top gainers and losers ↗
The regular session of the US market on Tuesday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements. 
Via Chartmill
News headline image
Earnings Scheduled For July 15, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For April 14, 2025 ↗
 
Via Benzinga
News headline image
This Norwegian Cruise Line Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗
 
Via Benzinga
News headline image
CoreWeave Opened For Trading In Biggest Tech IPO Since 2021 ↗
Shares of Nvidia-backed CoreWeave opened for trading on Friday, raising $1.5 billion and making it the biggest U.S. tech IPO since 2021, even after it was priced below the expected range. 
Via Talk Markets
Topics Initial Public Offering Stocks / Equities
News headline image
Kestra Opens For Trading, Discord Discusses Potential IPO ↗
Shares of Kestra Medical, a wearable cardiac device maker, soared in the company's public debut this week. Meanwhile, Discord is said to be in talks for a possible IPO in 2025. 
Via Talk Markets
Topics Initial Public Offering Stocks / Equities
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.